Back to
Woodline Partners LP
SUPN17 quarters
Position history for
Woodline Partners LP's holdings in SUPERNUS PHARMACEUTICALS
Woodline Partners LP holds 708,276 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $32.9M as of 2026-Q2. The position was increased (+57.8% shares). SUPN represents 0.1% of Woodline Partners LP's portfolio.
Current Value
$32.9M
Current Shares
708,276
Total Value Change
+$31.5M
Total Shares Change
+654,361
Quarter-by-Quarter History
Other major holders of SUPN: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.